NASDAQ:VIH

VPC Impact Acquisition (VIH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.33
$0.37
50-Day Range
$8.03
$36.23
52-Week Range
$9.07
$22.56
Volume
2.84 million shs
Average Volume
1.05 million shs
Market Capitalization
$9.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VIH stock logo

About VPC Impact Acquisition Stock (NASDAQ:VIH)

VPC Impact Acquisition Holdings is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based headquartered in Chicago, Illinois.

VIH Stock News Headlines

Focus Impact Acquisition Corp (FIAC)
DevvStream Reaches Key Milestone Toward Nasdaq Listing
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
BKKT Bakkt Holdings, Inc.
See More Headlines
Receive VIH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VPC Impact Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
NASDAQ:VIH
Phone
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.79 per share

Miscellaneous

Free Float
N/A
Market Cap
$9.56 million
Optionable
No Data
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. John G. Martin (Age 61)
    Chairman & CEO
  • Mr. Gordon Watson (Age 42)
    Pres, COO & Director
  • Ms. Olibia Stamatoglou (Age 41)
    Chief Financial Officer

This page (NASDAQ:VIH) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners